Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1992:284 Suppl 1:S22-6.
doi: 10.1007/BF00638236.

Peptides and cytokines

Affiliations
Review

Peptides and cytokines

J M Schröder. Arch Dermatol Res. 1992.

Abstract

In the last decade a number of proteinaceous inflammatory mediators have been structurally characterized. Two of these mediators, tumor necrosis factor alpha (TNF alpha) and Interleukin 1 alpha and beta (IL-1), have pleiotropic properties. Both cytokines are now known to be potent inducers of a number of cell-selective chemotactic cytokines, which belong to a novel superfamily of structurally related low-molecular-weight proteins. One of the most prominent members is termed "IL-8" and represents a neutrophil-selective attractant, whereas another one called "monocyte chemotactic protein 1 (MCP-1)" is a monocyte-selective chemotaxin. Other members seem to be selective chemotaxins for other leukocyte types and subsets. These chemotactic cytokines are produced by a variety of different cells under appropriate stimulation conditions. Large amounts of IL-8 have been detected in scales of psoriatic lesions and may be of importance in explaining predominant neutrophil infiltration in psoriatic lesions. Regulation of gene expression and/or release of these chemotactic cytokines may occur by IL-1 receptor antagonists or soluble TNF-alpha-receptors. So far, natural antagonists to these chemotactic cytokines have not been described; however, pharmacological inhibition of its gene expression and/or release is possible.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1989 Nov 1;170(5):1745-50 - PubMed
    1. J Immunol. 1987 Nov 15;139(10):3474-83 - PubMed
    1. J Immunol. 1987 May 15;138(10):3403-7 - PubMed
    1. Blood. 1992 Jan 1;79(1):45-51 - PubMed
    1. J Invest Dermatol. 1991 Jul;97(1):73-9 - PubMed

LinkOut - more resources